Lung cancer care is quickly evolving, and biomarker-based therapies have opened up new possibilities for people with advanced non-small cell lung cancer (#NSCLC). ➡️ Learn about more about NSCLC from the Lung Cancer Foundation of America: https://amgen.ly/46WAW3V
Insightful
Felix Perez, CEO Research Director
2moLung cancer treatment is advancing rapidly with the rise of biomarker-based therapies, offering new hope for those with advanced NSCLC. #NSCLC